Hypoparathyroidism due to 22Q11 Deletion Syndrome Presenting as Acute Cardiomyopathy

ABSTRACT: Objective: Discuss a unique presentation of hypoparathyroidism, an orphan disease with an estimated prevalence of 37 per 100,000 person-years in the United States.Methods: Describe the clinical presentation and pertinent laboratory data of a case of newly diagnosed hypoparathyroidism prese...

Full description

Bibliographic Details
Main Authors: Rahul Agarwal, MD, Staci Kallish, DO, Mona Al Mukaddam, MD, MS
Format: Article
Language:English
Published: Elsevier 2018-11-01
Series:AACE Clinical Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060520301358
id doaj-6792af32e09f465cb5fb52735426d8e8
record_format Article
spelling doaj-6792af32e09f465cb5fb52735426d8e82021-04-30T07:23:40ZengElsevierAACE Clinical Case Reports2376-06052018-11-0146e467e471Hypoparathyroidism due to 22Q11 Deletion Syndrome Presenting as Acute CardiomyopathyRahul Agarwal, MD0Staci Kallish, DO1Mona Al Mukaddam, MD, MS2From the Divisions of Endocrinology, Diabetes and Metabolism, University of Pennsylvania, Philadelphia, Pennsylvania.Translational Medicine and Human Genetics, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaFrom the Divisions of Endocrinology, Diabetes and Metabolism, University of Pennsylvania, Philadelphia, Pennsylvania.; Address correspondence to Dr. Mona Al Mukaddam, University of Pennsylvania Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, 3737 Market Street, 3rd Floor, Philadelphia, PA 19104.ABSTRACT: Objective: Discuss a unique presentation of hypoparathyroidism, an orphan disease with an estimated prevalence of 37 per 100,000 person-years in the United States.Methods: Describe the clinical presentation and pertinent laboratory data of a case of newly diagnosed hypoparathyroidism presenting as acute cardiomyopathy. A related literature review is also included.Results: A 34-year-old, previously healthy Caucasian female presented to the emergency room with progressive symptoms of heart failure and was found to have anemia, hypocalcemia, and hypoparathyroidism with an ejection fraction (EF) of 25 to 30% without structural cardiac abnormalities. Her labs revealed her hemoglobin was 6.4 g/dL, calcium was 4.9 mg/dL (reference range is 8.5 to 10.2 mg/dL), albumin was 3.4 g/dL (reference range is 3.5 to 5.5 g/dL), magnesium was 1.3 mg/dL (reference range is 1.7 to 2.2 mg/dL), phosphate was 4.9 mg/dL (reference range is 2.5 to 4.5 mg/dL), parathyroid hormone was 9 pg/mL (reference range is 14 to 64 pg/mL), and 25-hydroxyvitamin D was 31.9 ng/mL (reference range is 30 to 79 ng/mL). Pertinent history included normal early development, no previous neck surgery or radiation, and no family history of hypocalcemia, seizures, or intellectual disability. The patient did note recurrent ear infections. On physical exam, the patient had a nasal voice but no dysmorphic facies or visible palatal abnormalities and a normal cardiac exam. The patient's EF improved to 35% by hospital day 8 with stabilization of calcium levels. In follow-up, her EF was 50 to 55% at 1 month and then 60% at 5 months. Genetic testing revealed 22q11.2 deletion.Conclusion: This is the first reported adult case of 22q11 deletion syndrome presenting with reversible heart failure due to hypocalcemia secondary to hypoparathyroidism. Genetic testing is recommended for all cases of hypoparathyroidism without a clear known etiology even if they present in adulthood.Abbreviations: 22q11DS = 22q11 deletion syndrome; EF = ejection fractionhttp://www.sciencedirect.com/science/article/pii/S2376060520301358
collection DOAJ
language English
format Article
sources DOAJ
author Rahul Agarwal, MD
Staci Kallish, DO
Mona Al Mukaddam, MD, MS
spellingShingle Rahul Agarwal, MD
Staci Kallish, DO
Mona Al Mukaddam, MD, MS
Hypoparathyroidism due to 22Q11 Deletion Syndrome Presenting as Acute Cardiomyopathy
AACE Clinical Case Reports
author_facet Rahul Agarwal, MD
Staci Kallish, DO
Mona Al Mukaddam, MD, MS
author_sort Rahul Agarwal, MD
title Hypoparathyroidism due to 22Q11 Deletion Syndrome Presenting as Acute Cardiomyopathy
title_short Hypoparathyroidism due to 22Q11 Deletion Syndrome Presenting as Acute Cardiomyopathy
title_full Hypoparathyroidism due to 22Q11 Deletion Syndrome Presenting as Acute Cardiomyopathy
title_fullStr Hypoparathyroidism due to 22Q11 Deletion Syndrome Presenting as Acute Cardiomyopathy
title_full_unstemmed Hypoparathyroidism due to 22Q11 Deletion Syndrome Presenting as Acute Cardiomyopathy
title_sort hypoparathyroidism due to 22q11 deletion syndrome presenting as acute cardiomyopathy
publisher Elsevier
series AACE Clinical Case Reports
issn 2376-0605
publishDate 2018-11-01
description ABSTRACT: Objective: Discuss a unique presentation of hypoparathyroidism, an orphan disease with an estimated prevalence of 37 per 100,000 person-years in the United States.Methods: Describe the clinical presentation and pertinent laboratory data of a case of newly diagnosed hypoparathyroidism presenting as acute cardiomyopathy. A related literature review is also included.Results: A 34-year-old, previously healthy Caucasian female presented to the emergency room with progressive symptoms of heart failure and was found to have anemia, hypocalcemia, and hypoparathyroidism with an ejection fraction (EF) of 25 to 30% without structural cardiac abnormalities. Her labs revealed her hemoglobin was 6.4 g/dL, calcium was 4.9 mg/dL (reference range is 8.5 to 10.2 mg/dL), albumin was 3.4 g/dL (reference range is 3.5 to 5.5 g/dL), magnesium was 1.3 mg/dL (reference range is 1.7 to 2.2 mg/dL), phosphate was 4.9 mg/dL (reference range is 2.5 to 4.5 mg/dL), parathyroid hormone was 9 pg/mL (reference range is 14 to 64 pg/mL), and 25-hydroxyvitamin D was 31.9 ng/mL (reference range is 30 to 79 ng/mL). Pertinent history included normal early development, no previous neck surgery or radiation, and no family history of hypocalcemia, seizures, or intellectual disability. The patient did note recurrent ear infections. On physical exam, the patient had a nasal voice but no dysmorphic facies or visible palatal abnormalities and a normal cardiac exam. The patient's EF improved to 35% by hospital day 8 with stabilization of calcium levels. In follow-up, her EF was 50 to 55% at 1 month and then 60% at 5 months. Genetic testing revealed 22q11.2 deletion.Conclusion: This is the first reported adult case of 22q11 deletion syndrome presenting with reversible heart failure due to hypocalcemia secondary to hypoparathyroidism. Genetic testing is recommended for all cases of hypoparathyroidism without a clear known etiology even if they present in adulthood.Abbreviations: 22q11DS = 22q11 deletion syndrome; EF = ejection fraction
url http://www.sciencedirect.com/science/article/pii/S2376060520301358
work_keys_str_mv AT rahulagarwalmd hypoparathyroidismdueto22q11deletionsyndromepresentingasacutecardiomyopathy
AT stacikallishdo hypoparathyroidismdueto22q11deletionsyndromepresentingasacutecardiomyopathy
AT monaalmukaddammdms hypoparathyroidismdueto22q11deletionsyndromepresentingasacutecardiomyopathy
_version_ 1721498473987047424